Stocktoria

Curanex Pharmaceuticals Inc CURX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-08-26

Curanex Pharmaceuticals Inc statistics & valuation

Market cap$7.5M
P / B0.7×
Return on equity-37.7%
Return on capital-37%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-71.80% -37.70% 20242025
Shares outstanding
24.0M 28.3M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-69.80% -36.50% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.03 -$0.17 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-36.5%-69.8%
Return on equity-37.7%-71.8%
Current ratio81.9335.54

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.